Search Within

Teresa Rasalan

Formats
  1. Journal Article (19)
  2. Meeting Abstract (14)
Groups
  1. Department of Medicine (33)
  2. Solid Tumor Oncology Division (33)
  3. Melanoma and Immunotherapeutics Service (26)
  4. GSK Faculty (25)
  5. Biostatistics Service (20)
  6. Epidemiology and Biostatistics (20)

More Groups

People
  1. Jedd Wolchok (24)
  2. Jianda Yuan (24)
  3. Humilidad Gallardo (21)
  4. Katherine Panageas (11)
  5. Phillip Wong (11)
  6. Stephanie Terzulli (10)

More People

Years
  1. 2025 (1)
  2. 2024 (3)
  3. 2023 (1)
  4. 2019 (2)
  5. 2018 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Journal of Immunotherapy (3)
  3. Blood (2)
  4. Cancer Research (2)
  5. Clinical Cancer Research (2)
  6. Cytotherapy (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (5)
  3. Lippincott Williams & Wilkins (3)
  4. Nature Publishing Group (3)
  5. American Society of Hematology (2)
  6. Elsevier Inc. (2)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Combining a WT1 vaccine (Galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1–expressing diffuse pleural mesothelioma: A phase 1 study
    Journal Article

    Agrawal, P.; Offin, M.; Lai, V.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
    JTO Clinical and Research Reports (2025)

    Fulltext@MSK | Save
  • Correlation of peripheral blood monocytic myeloid-derived suppressor cells (M-MDSC) and T-cell receptor (TCR) dynamics with clinical outcomes in patients (pts) with metastatic urothelial carcinoma (mUC) treated with nivolumab (NIVO)
    Meeting Abstract

    Gupta, A.; Whiting, K.; Keegan, N. M.; Schmalz, J.; Al-Ahmadie, H. A.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Iyer, G.; Rosenberg, J. E.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Combining a WT1 cancer vaccine (galinpepimut-S) with checkpoint inhibition (nivolumab) in patients with WT1-expressing diffuse pleural mesothelioma (DPM): A phase I study
    Meeting Abstract

    Agrawal, P.; Offin, M.; Ginsberg, M. S.; Adusumilli, P. S.; Rusch, V. W.; Sauter, J. L.; Ho, T.; Wong, P.; Zauderer, M. G.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Preoperative immune checkpoint inhibition and cryoablation in early-stage breast cancer
    Journal Article

    Comen, E.; Budhu, S.; Elhanati, Y.; Page, D.; Rasalan-Ho, T.; Ritter, E.; Wong, P.; Plitas, G.; Patil, S.; Brogi, E.; more...
    iScience (2024)

    Fulltext@MSK | Save
  • Phase I study of a multivalent WT1 peptide vaccine (galinpepimut-S) in combination with nivolumab in patients with WT1-expressing ovarian cancer in second or third remission
    Journal Article

    Manning-Geist, B. L.; Gnjatic, S.; Aghajanian, C.; Konner, J.; Kim, S. H.; Sarasohn, D.; Soldan, K.; Tew, W. P.; Sarlis, N. J.; Zamarin, D.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Preoperative checkpoint inhibition (CPI) and cryoablation (Cryo) in women with early-stage breast cancer (ESBC)
    Meeting Abstract

    Comen, E. A.; Bryce, Y.; Page, D. B.; Solomon, S. B.; Rodine, M.; Abaya, C. D.; Morris, E. A.; Plitas, G.; El-Tamer, M.; Gemignani, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Binimetinib plus gemcitabine and cisplatin phase I/II trial in patients with advanced biliary cancers
    Journal Article

    Lowery, M. A.; Bradley, M.; Chou, J. F.; Capanu, M.; Gerst, S.; Harding, J. J.; El Dika, I.; Berger, M.; Zehir, A.; Ptashkin, R.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
    Journal Article

    Rizvi, N. A.; Hellmann, M. D.; Snyder, A.; Kvistborg, P.; Makarov, V.; Havel, J. J.; Lee, W.; Yuan, J.; Wong, P.; Ho, T. S. ; more...
    Science (2015)

    Fulltext@MSK | Save
  • Genetic basis for clinical response to CTLA-4 blockade in melanoma
    Journal Article

    Snyder, A.; Makarov, V.; Merghoub, T.; Yuan, J.; Zaretsky, J. M.; Desrichard, A.; Walsh, L. A.; Postow, M. A.; Wong, P.; Ho, T. S. ; more...
    New England Journal of Medicine (2014)

    Fulltext@MSK | Save